Αρχειοθήκη ιστολογίου

Κυριακή 28 Ιανουαρίου 2018

Metastatic Renal Cell Cancer—Systemic Therapy

Abstract

Management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the past 10 years due to better understanding of tumor biology. This development has changed mRCC to a chronic progressive disease with several lines of treatment options. The introduction of several new targeted therapies including immunotherapy has improved median overall survival of approximately 1 year to >2 years in mRCC.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2nis6cd

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου